Adversarial deep evolutionary learning for drug design
- PMID: 36228831
- DOI: 10.1016/j.biosystems.2022.104790
Adversarial deep evolutionary learning for drug design
Abstract
The design of a new therapeutic agent is a time-consuming and expensive process. The rise of machine intelligence provides a grand opportunity of expeditiously discovering novel drug candidates through smart search in the vast molecular structural space. In this paper, we propose a new approach called adversarial deep evolutionary learning (ADEL) to search for novel molecules in the latent space of an adversarial generative model and keep improving the latent representation space. In ADEL, a custom-made adversarial autoencoder (AAE) model is developed and trained under a deep evolutionary learning (DEL) process. This involves an initial training of the AAE model, followed by an integration of multi-objective evolutionary optimization in the continuous latent representation space of the AAE rather than the discrete structural space of molecules. By using the AAE, an arbitrary distribution can be provided to the training of AAE such that the latent representation space is set to that distribution. This allows for a starting latent space from which new samples can be produced. Throughout the process of learning, new samples of high quality are generated after each iteration of training and then added back into the full dataset, therefore, allowing for a more comprehensive procedure of understanding the data structure. This combination of evolving data and continuous learning not only enables improvement in the generative model, but the data as well. By comparing ADEL to the previous work in DEL, we see that ADEL can obtain better property distributions. We show that ADEL is able to design high-quality molecular structures which can be further used for virtual and experimental screenings.
Keywords: Adversarial autoencoder; Adversarial deep evolutionary learning; Deep evolutionary learning; Drug design; Multi-objective optimization; Virtual screening.
Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.Mol Pharm. 2017 Sep 5;14(9):3098-3104. doi: 10.1021/acs.molpharmaceut.7b00346. Epub 2017 Aug 4. Mol Pharm. 2017. PMID: 28703000
-
The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology.Oncotarget. 2017 Feb 14;8(7):10883-10890. doi: 10.18632/oncotarget.14073. Oncotarget. 2017. PMID: 28029644 Free PMC article.
-
Adversarial autoencoder for visualization and classification of human activity: Application to a low-cost commercial force plate.J Biomech. 2020 Apr 16;103:109684. doi: 10.1016/j.jbiomech.2020.109684. Epub 2020 Feb 26. J Biomech. 2020. PMID: 32213290
-
Generative chemistry: drug discovery with deep learning generative models.J Mol Model. 2021 Feb 4;27(3):71. doi: 10.1007/s00894-021-04674-8. J Mol Model. 2021. PMID: 33543405 Free PMC article. Review.
-
Generative machine learning for de novo drug discovery: A systematic review.Comput Biol Med. 2022 Jun;145:105403. doi: 10.1016/j.compbiomed.2022.105403. Epub 2022 Mar 13. Comput Biol Med. 2022. PMID: 35339849 Review.
Cited by
-
Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening.J Chem Inf Model. 2024 May 13;64(9):3826-3840. doi: 10.1021/acs.jcim.4c00234. Epub 2024 May 2. J Chem Inf Model. 2024. PMID: 38696451 Free PMC article.
-
Integrating transformers and many-objective optimization for drug design.BMC Bioinformatics. 2024 Jun 8;25(1):208. doi: 10.1186/s12859-024-05822-6. BMC Bioinformatics. 2024. PMID: 38849719 Free PMC article.
-
Augmenting genetic algorithms with machine learning for inverse molecular design.Chem Sci. 2024 Sep 11;15(38):15522-39. doi: 10.1039/d4sc02934h. Online ahead of print. Chem Sci. 2024. PMID: 39296997 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources